Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1995 Jul;74(1):18–20. doi: 10.1136/hrt.74.1.18

Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis.

R Carlsson 1, G Lindberg 1, L Westin 1, B Israelsson 1
PMCID: PMC483940  PMID: 7662447

Abstract

OBJECTIVE--To compare serum concentrations of total cholesterol, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, and triglycerides four weeks after acute myocardial infarction with baseline levels measured within 24 hours after onset of symptoms. DESIGN--A prospective study including 141 patients with acute myocardial infarction who were admitted to the coronary care unit at a general hospital. MEASUREMENTS--Fasting serum concentrations of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. MAIN RESULTS--In patients receiving thrombolytic therapy, no significant differences were found in serum lipids four weeks after admission compared to values estimated within 24 hours from onset of symptoms. In patients not receiving thrombolytic therapy, total cholesterol and low density lipoprotein cholesterol showed a minor increase four weeks after admission compared to values obtained within 24 hours after onset of symptoms. High density lipoprotein cholesterol and triglycerides remained unchanged. CONCLUSIONS--In patients with acute myocardial infarction receiving thrombolytic therapy, serum lipids measured four weeks after onset of infarction are reasonably valid estimates of baseline lipid levels and may be used to decide about lipid lowering interventions. This information can be a basis for actions against hyperlipidaemia early after hospital discharge when the patient is highly motivated to change lifestyles and is still in close contact with a cardiologist or other physician.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahnve S., Angelin B., Edhag O., Berglund L. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med. 1989 Nov;226(5):297–301. doi: 10.1111/j.1365-2796.1989.tb01399.x. [DOI] [PubMed] [Google Scholar]
  2. Avogaro P., Bon G. B., Cazzolato G., Quinci G. B., Sanson A., Sparla M., Zagatti G. C., Caturelli G. Variations in apolipoproteins B and A1 during the course of myocardial infarction. Eur J Clin Invest. 1978 Jun;8(3):121–129. doi: 10.1111/j.1365-2362.1978.tb00824.x. [DOI] [PubMed] [Google Scholar]
  3. Ballantyne F. C., Melville D. A., McKenna J. P., Morrison B. A., Ballantyne D. Response of plasma lipoproteins and acute phase proteins to myocardial infarction. Clin Chim Acta. 1979 Nov 15;99(1):85–92. doi: 10.1016/0009-8981(79)90142-6. [DOI] [PubMed] [Google Scholar]
  4. Enger S. C., Ritland S. Serum lipoprotein pattern in myocardial infarction. Acta Med Scand. 1970 May;187(5):365–369. doi: 10.1111/j.0954-6820.1970.tb02957.x. [DOI] [PubMed] [Google Scholar]
  5. Fyfe T., Baxter R. H., Cochran K. M., Booth E. M. Plasma-lipid changes after myocardial infarction. Lancet. 1971 Nov;2(7732):997–1001. doi: 10.1016/s0140-6736(71)90322-9. [DOI] [PubMed] [Google Scholar]
  6. Gore J. M., Goldberg R. J., Matsumoto A. S., Castelli W. P., McNamara P. M., Dalen J. E. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol. 1984 Oct 1;54(7):722–725. doi: 10.1016/s0002-9149(84)80197-6. [DOI] [PubMed] [Google Scholar]
  7. Jackson R., Scragg R., Marshall R., White H., O'Brien K., Small C. Changes in serum lipid concentrations during first 24 hours after myocardial infarction. Br Med J (Clin Res Ed) 1987 Jun 20;294(6587):1588–1589. doi: 10.1136/bmj.294.6587.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mundy G. R., McPherson D. G. Variations in serum cholesterol levels after myocardial infarction. Med J Aust. 1973 Feb 10;1(6):278–282. doi: 10.5694/j.1326-5377.1973.tb119743.x. [DOI] [PubMed] [Google Scholar]
  9. Pietilä K., Harmoinen A., Teppo A. M. Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med. 1991;23(5):529–535. doi: 10.3109/07853899109150513. [DOI] [PubMed] [Google Scholar]
  10. Ritland S., Blomhoff J. P., Enger S. C., Skrede S., Gjone E. The esterification of cholesterol in plasma after acute myocardial infarction. Scand J Clin Lab Invest. 1975 Mar;35(2):181–187. [PubMed] [Google Scholar]
  11. Rosenson R. S. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol. 1993 Sep;22(3):933–940. doi: 10.1016/0735-1097(93)90213-k. [DOI] [PubMed] [Google Scholar]
  12. Ryder R. E., Hayes T. M., Mulligan I. P., Kingswood J. C., Williams S., Owens D. R. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J (Clin Res Ed) 1984 Dec 15;289(6459):1651–1653. doi: 10.1136/bmj.289.6459.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sewdarsen M., Vythilingum S., Jialal I., Nadar R. Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction. Postgrad Med J. 1988 May;64(751):352–356. doi: 10.1136/pgmj.64.751.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. TIBBLIN G., CRAMER K. SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS. Acta Med Scand. 1963 Oct;174:451–455. doi: 10.1111/j.0954-6820.1963.tb07944.x. [DOI] [PubMed] [Google Scholar]
  15. Wolinsky H. The effects of beta-adrenergic blocking agents on blood lipid levels. Clin Cardiol. 1987 Oct;10(10):561–566. doi: 10.1002/clc.4960101010. [DOI] [PubMed] [Google Scholar]
  16. Yusuf S., Collins R., Peto R., Furberg C., Stampfer M. J., Goldhaber S. Z., Hennekens C. H. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985 Jul;6(7):556–585. doi: 10.1093/oxfordjournals.eurheartj.a061905. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES